In contrast to our findings, Szajnik et al. suggested that HSD17B12 overexpression is related to a poor prognosis for ovarian carcinoma [54], but Etienne et al. found no relationship with PFS for breast cancer [55]. Here, HSD17B12 is linked to ovarian carcinoma.